The Embolotherapy Market Research Report covers business strategies, qualitative and quantitative analysis, and emerging industry trends. It is a detailed and significant study. The study conducts a complete examination and analysis of the key elements of the global Embolotherapy market. The research analysts created this report after carefully examining the drivers, restraints, challenges, trends, and opportunities in the global Embolotherapy market.
The global embolotherapy market size reached USD 3.50 Billion in 2020 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to the latest analysis by Emergen Research. The increasing prevalence of chronic diseases such as cancer, peripheral artery disease, and neurological disorders, among others, is a key factor driving global embolotherapy market revenue growth. A steady transition towards minimally invasive procedures from invasive open surgical procedures is expected to continue to drive revenue growth in the global embolotherapy market. Increasing demand for image-guided minimally invasive interventions has not only broadened the scope of vascular pathologies that can be treated but has also resulted in a reduction of post-operative morbidity compared to open surgical techniques. Embolization is an advanced form of treatment option whereby tiny equipment is used to navigate the body’s vasculature without the need for a wound incision or open surgery. This enables reduced complication rates, increases success rates, and improves the quality of life of patients.
The latest study provides an insightful analysis of the broad competitive landscape of the global Embolotherapy market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Embolotherapy market and pinpoint the fundamental growth trends.
The leading market contenders listed in the report are:
Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Terumo Medical Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., Cook Medical Inc., Kaneka Corporation, and Stryker Corporation
Global Embolotherapy Market Highlights:
Regional demand estimation and forecast
Product Mix Matrix
R&D Analysis
Cost-Benefit Analysis
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Competitive Analysis
Mergers & Acquisitions
Location Quotients Analysis
Carbon Footprint Analysis
Patent Analysis
Vendor Management
Key Parameters Analyzed in This Section:
Company Profiles
Gross Revenue
Profit margins
Product sales trends
Product pricing
Industry Analysis
Sales & distribution channels
Regional Segmentation:
North America
Latin America
Europe
Middle East & Africa
Asia Pacific
Key Points Covered in This Section:
Regional contribution
Estimated revenue generation
Vital data and information about the consumption rate in all the leading regional segments
Embolic agents segment is expected to account for largest revenue share over the forecast period due to increasing use of calibrated microscopes, biodegradable microspherical embolic agents and increasing development of next generation liquid embolics for facilitating treatment of a variety of pathological disease.
Transcatheter arterial radioembolization segment revenue is expected to expand at a rapid CAGR over the forecast period owing to rising popularity of this therapeutic modality for effectively treating both primary and secondary hepatobilary disease and increasing investment to develop next generation radioembolic devices to improve clinical outcomes.
Cancer segment is expected to account for largest revenue share over the forecast period owing to rising prevalence of liver cancer and increasing number of transarterial chemoembolization procedures performed for controlling tumor growth and destroying cancer cells and providing quality care to patients suffering with liver cancer.
Ambulatory surgical segment is expected to register a significantly robust CAGR in terms of revenue over the forecast period due to increasing preference for outpatient surgical procedures, increasing patient admissions in these facilities, availability of reimbursement, and increasing number of embolotherapy surgical procedures performed at these facilities.
North America is expected to account largest revenue share over the forecast period due to rising number of clinical trials for assessing safety and efficacy of embolization in a wide range of applications and increasing use of Drug-Elating Bead Transarterial Chemoembolization (DEB-TACE)
Market Overview:
The report bifurcates the Embolotherapy market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Product Outlook (Revenue, USD Billion; 2018–2028)
Embolic Agents
Liquid Embolic Agents
Microspheres
Embolization Coils
Detachable Coils
Pushable Coils
Detachable Balloons
Embolic Plug Systems
Support Devices
Microcatheters
Guidewires
Procedure Outlook (Revenue, USD Billion; 2018–2028)
Transcatheter Arterial Embolization
Transcatheter Arterial Radioembolization
Transcatheter Chemoembolization
Application Outlook (Revenue, USD Billion; 2018–2028)
Key reasons to buy the Global Embolotherapy Market report:
The latest report comprehensively studies the global Embolotherapy market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
The report offers an insightful analysis of the regional outlook of the market.
It offers a detailed account of the end-use applications of the products services offered by this industry.
The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
